Santhera Pharmaceuticals Holding AG (0QN1.L) LSE
15.40
-0.7089(-4.40%)
Currency In CHF
- General
- Statistics
- Historical Data
- Profile
- Financials
15.40
-0.7089(-4.40%)
Currency In CHF
| Market Cap | 163.98M |
| Enterprise Value | 239.31M |
| P/E Ratio | -4.13 |
| PEG Ratio | 0.14 |
| Price/Sales Ratio | 2.86 |
| Price/Book Ratio | -17.23 |
| Enterprise/Revenue | 3.84 |
| Enterprise/EBITDA | -9.66 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | -0.64 |
| Operating Margin | -0.49 |
| Return On Assets | -0.33 |
| Return On Equity | 6.85 |
| Revenue | 77.19M |
| Revenue/Share | 5.76 |
| Gross Profit | 14.47M |
| EBITDA | -32.13M |
| Net Income | -49.24M |
| Diluted EPS | -3.78 |
| Total Cash | 22.44M |
| Total Cash/Share | 1.68 |
| Total Debt | 97.77M |
| Total Debt/Equity | -8.27 |
| Current Ratio | 1.29 |
| Book Value Per Share | -0.88 |
| 52-Week Change | 16.49 |
| 52-Week High | 15.88 |
| 52-Week Low | 6.15 |
| Moving Average 50 Days | 9.91 |
| Moving Average 200 Days | 8.98 |
| Average Volume | 1,302 |
| Shares Outstanding | 13.01M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:10 |
| Last Split Date | July 03, 2023 |